Beam Therapeutics Inc
(BEAM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2001 | 12-2000 | 12-1999 | 12-1998 | |
| Cash Flows From Operating Activities | ||||
| Net Income | 386,000 | -137,700 | -890,600 | 263,100 |
| Depreciation Amortization | 218,700 | 739,300 | 1,356,500 | 251,100 |
| Income taxes - deferred | -88,100 | 34,000 | 1,200 | 44,000 |
| Accounts receivable | 37,000 | -22,600 | -24,400 | -38,000 |
| Accounts payable and accrued liabilities | 36,600 | -52,500 | -68,600 | -63,100 |
| Other Working Capital | 48,600 | -154,200 | -122,000 | -172,800 |
| Other Operating Activity | -100 | 66,100 | 236,300 | 119,900 |
| Operating Cash Flow | $638,700 | $472,400 | $488,400 | $404,200 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -204,000 | -212,200 | -217,300 | -245,400 |
| Net Acquisitions | 273,500 | N/A | N/A | 17,000 |
| Purchase Of Investment | N/A | -25,600 | -132,300 | -271,800 |
| Other Investing Activity | 270,200 | -200 | 400 | -2,600 |
| Investing Cash Flow | $339,700 | $-238,000 | $-349,200 | $-502,800 |
| Cash Flows From Financing Activities | ||||
| Change In Short Term Borrowing | -950,900 | 159,400 | 316,500 | 92,800 |
| Debt Issued | N/A | N/A | 226,300 | 624,100 |
| Debt Repayment | -13,700 | -43,400 | -182,600 | -376,000 |
| Common Stock Issued | 54,000 | 2,700 | 80,400 | 56,600 |
| Common Stock Repurchased | -272,800 | -256,100 | -397,700 | -112,000 |
| Dividend Paid | -148,000 | -147,700 | -149,600 | -147,400 |
| Other Financing Activity | 378,600 | 1,100 | -600 | -47,900 |
| Financing Cash Flow | $-952,800 | $-284,000 | $-107,300 | $90,200 |
| Exchange Rate Effect | 2,200 | -1,400 | -300 | -5,500 |
| Beginning Cash Position | 20,900 | 71,900 | 40,300 | 54,200 |
| End Cash Position | 48,700 | 20,900 | 71,900 | 40,300 |
| Net Cash Flow | $27,800 | $-51,000 | $31,600 | $-13,900 |
| Free Cash Flow | ||||
| Operating Cash Flow | 638,700 | 472,400 | 488,400 | 404,200 |
| Capital Expenditure | -207,300 | -227,200 | -240,500 | -251,900 |
| Free Cash Flow | 431,400 | 245,200 | 247,900 | 152,300 |